CureVac

BUSINESS

GlaxoSmithKline and CureVac to make Covid vaccines targeting new variants

Digital Desk - Feb 3, 2021

GlaxoSmithKline has said it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of Covid-19 amid concerns that some...

NEWS

GSK throws £130m behind innovative vaccine developer CureVac

Digital Desk - Jul 20, 2020

British drug giant GlaxoSmithKline has backed a “cutting edge” player in the race to develop a vaccine for coronavirus. GSK said it was putting £130...